Slingshot Insights | Planatome Surgical Overview

PLANATOME SURGICAL Overview

Upcoming Projects (PLANATOME SURGICAL)

Discussing BridgeBio Pharma Inc.'s recent Phase 3 results for Attruby, a TTR stabilizer which reduces cardiovascular death and cardiovascular-related hospitalization in ATTR-CM patients.
Tickers: BBIO, Planatome Surgical
Execute By: Dec 31, 2024

Executed Projects (PLANATOME SURGICAL)

Third View: Discussing Planatome's nanopolished surgical bladed, that reduces hypertrophic scarring by 86%.
Ticker: PLANATOME SURGICAL
Executed On: Dec 05, 2024 at 04:00 PM EST
Second View: Discussing Planatome's nanopolished surgical bladed, that reduces hypertrophic scarring by 86%.
Ticker: PLANATOME SURGICAL
Executed On: Dec 04, 2024 at 02:00 PM EST
Discussing Planatome's nanopolished surgical bladed, that reduces hypertrophic scarring by 86%.
Ticker: PLANATOME SURGICAL
Executed On: Nov 21, 2024 at 12:30 PM EST

Upcoming & Overdue Catalysts (PLANATOME SURGICAL)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (PLANATOME SURGICAL)

Don’t see a strategic initiative related to the company you care about? Create your own!